MedPath

Surveillance for Multifocal GGNs

Recruiting
Conditions
Lung Ground-glass Opacities
Active Surveillance
Registration Number
NCT06097910
Lead Sponsor
Fudan University
Brief Summary

This study is a single-arm, multi-center, phase III trial conducted under the Eastern Cooperative Thoracic Oncoloy Project (ECTOP) with the identification number ECTOP-1021. The primary objective of the study is to assess the overall survival of patients with multifocal ground-glass opacities by employing a watchful waiting approach rather than opting for surgical resection.

Detailed Description

The trial aims to confirm the hypotheses that delaying surgery until GGO nodules exhibit progression or meet certain criteria offers a prognosis equivalent to those undergoing immediate surgical resection, potentially allowing many of these patients to avoid surgery altogether. Surgical criteria are met if any of the lesions exhibit progression (with a maximal diameter increase of more than 1.5mm or the apperance of a solid component) or as determined by each institution.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
370
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5-year overall survival5 years

The event is defined as the death due to any causes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fudan University Cancer Center

🇨🇳

Shanghai, Shanghai, China

Fudan University Cancer Center
🇨🇳Shanghai, Shanghai, China
Chen Haiquan, MD
Contact
+86-21 64175590
hqchen1@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.